AAV9-LSP-G6PC1

N/A

Report date: 2025/01/26 18:11:30

Base Information

Drug NameAAV9-LSP-G6PC1
Drug Alias NameAAV9-based gene therapy (Genethon)AAV9-G6PC1 gene therapy (Genethon)AAV9-LSP-G6PC1
ClassificationBiologics
Mechanisms of ActionGlucose-6-phosphatase stimulants
TargetsGlucose-6-phosphatase
Therapy Area/IndicationsGlycogen Storage Disease Type I
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGenethon
China Registration ClassN/A

Develop Information

Active CompaniesGenethon
Inactive CompaniesN/A
Active IndicationsGlycogen Storage Disease Type I
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A